TARRYTOWN, N.Y. and PARIS, April 18, 2025 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc...
Category - New Drugs
U.S. Food and Drug Administration Updates Camzyos (mavacamten)...
PRINCETON, N.J.– April 17, 2025 — (BUSINESS WIRE)– Bristol Myers Squibb (NYSE:...
FDA Grants Isturisa (osilodrostat) Expanded Indication for the Treatment of Endogenous Hypercortisolemia in Patients with Cushing’s Syndrome
Neurelis Announces FDA Approval for Immediate Use Seizure Medication Valtoco (diazepam nasal spray) in Ages 2 to 5 Years
Mirum’s Livmarli Now FDA Approved in Tablet Formulation
FDA Grants Interchangeable Designation to Yuflyma (adalimumab-aaty), Celltrion’s Biosimilar to Humira (adalimumab)
FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as a First-Line Treatment for Unresectable or Metastatic Hepatocellular Carcinoma
FDA Approves Jobevne (bevacizumab-nwgd), a Biosimilar to Avastin
Argenx Announces FDA Approval of Vyvgart Hytrulo Prefilled Syringe for Self-Injection